| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bart van der Worp
|
|
|
2014
|
13 |
5 |
p. 450-
1 p.
|
article
|
| 2 |
Corrections
|
|
|
2014
|
13 |
5 |
p. 446-
1 p.
|
article
|
| 3 |
Corrections
|
|
|
2014
|
13 |
5 |
p. 446-
1 p.
|
article
|
| 4 |
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial
|
Giovannoni, Gavin
|
|
2014
|
13 |
5 |
p. 472-481
10 p.
|
article
|
| 5 |
Daclizumab in multiple sclerosis: a high-yield extension study
|
Barkhof, Frederik
|
|
2014
|
13 |
5 |
p. 443-444
2 p.
|
article
|
| 6 |
Distinct neurological disorders with ATP1A3 mutations
|
Heinzen, Erin L
|
|
2014
|
13 |
5 |
p. 503-514
12 p.
|
article
|
| 7 |
End-of-life decisions in patients with severe acute brain injury
|
Geurts, Marjolein
|
|
2014
|
13 |
5 |
p. 515-524
10 p.
|
article
|
| 8 |
Gallantly fighting windmills? Complexity of a 21st century challenge
|
Pierce, Robin
|
|
2014
|
13 |
5 |
p. 451-
1 p.
|
article
|
| 9 |
Gardens that take care of us
|
Burton, Adrian
|
|
2014
|
13 |
5 |
p. 447-448
2 p.
|
article
|
| 10 |
Luis Velázquez-Pérez: helping to put SCA2 in the spotlight
|
Holmes, David
|
|
2014
|
13 |
5 |
p. 449-
1 p.
|
article
|
| 11 |
Neurological complications of cardiac surgery
|
McDonagh, David L
|
|
2014
|
13 |
5 |
p. 490-502
13 p.
|
article
|
| 12 |
Neuropsychiatric outcomes of stroke
|
Hackett, Maree L
|
|
2014
|
13 |
5 |
p. 525-534
10 p.
|
article
|
| 13 |
News in brief
|
|
|
2014
|
13 |
5 |
p. 452-
1 p.
|
article
|
| 14 |
Orexin receptor antagonists: a new treatment for insomnia?
|
Riemann, Dieter
|
|
2014
|
13 |
5 |
p. 441-443
3 p.
|
article
|
| 15 |
Palliative and end-of-life care should not be last or least
|
The Lancet Neurology,
|
|
2014
|
13 |
5 |
p. 439-
1 p.
|
article
|
| 16 |
Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study
|
Velázquez-Pérez, Luis
|
|
2014
|
13 |
5 |
p. 482-489
8 p.
|
article
|
| 17 |
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
|
Michelson, David
|
|
2014
|
13 |
5 |
p. 461-471
11 p.
|
article
|
| 18 |
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial
|
Chamorro, Ángel
|
|
2014
|
13 |
5 |
p. 453-460
8 p.
|
article
|
| 19 |
Spinocerebellar ataxia type 2: progression before diagnosis
|
Klockgether, Thomas
|
|
2014
|
13 |
5 |
p. 445-446
2 p.
|
article
|
| 20 |
Tackling ataxia
|
Goodrick, Steven
|
|
2014
|
13 |
5 |
p. 450-
1 p.
|
article
|
| 21 |
Uric acid for stroke: glimmer of hope or false dawn?
|
Campbell, Bruce CV
|
|
2014
|
13 |
5 |
p. 440-441
2 p.
|
article
|
Journal description